GENFIT Share Price Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
||
| 9.715 EUR | 0.00% |
|
| 09/06 | Genfit flat despite positive news and Kepler Cheuvreux backing |  |
| 09/06 | Genfit's NIS4-powered NASHnext test now available on Labcorp OnDemand | |
| Market Cap | 46Cr 53Cr 42Cr 40Cr 75Cr 5.07TCr 76Cr 501.72Cr 195.62Cr 2.47TCr 200.36Cr 196.1Cr 8.55TCr | P/E Ratio 2025 |
-3.06x | P/E Ratio 2026 * | 48.7x |
|---|---|---|---|---|---|
| Enterprise Value | 41Cr 47Cr 37Cr 35Cr 66Cr 4.47TCr 67Cr 442.18Cr 172.4Cr 2.18TCr 176.58Cr 172.83Cr 7.54TCr | EV / Sales 2025 |
2.34x | EV / Sales 2026 * | 4.35x |
| Free-Float |
86.88% | Yield 2025 * |
-
| Yield 2026 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.32% | +1.41% | -12.49% | -12.11% | 4.3TCr | |
| +3.11% | +3.11% | +279.08% | +509.39% | 3.27TCr | |
| +0.22% | -1.08% | +15.66% | -14.70% | 3.03TCr | |
| +1.62% | -2.08% | -1.91% | +27.08% | 2.94TCr | |
| +4.09% | +0.93% | +12.97% | +20.66% | 2.51TCr | |
| +1.14% | +3.62% | - | - | 1.35TCr | |
| -1.63% | +2.88% | +56.69% | +114.08% | 1.33TCr | |
| -0.09% | -1.36% | +4.51% | +6.03% | 1.3TCr | |
| -0.74% | -1.62% | +105.89% | +79.51% | 1.21TCr | |
| Average | +0.84% | +1.45% | +57.55% | +91.24% | 2.36TCr | |
| Weighted average by Cap. | +1.18% | +1.48% | +57.47% | +98.40% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 6.68Cr 7.74Cr 6.16Cr 5.76Cr 11Cr 735.31Cr 11Cr 73Cr 28Cr 357.9Cr 29Cr 28Cr 1.24TCr | 9.52Cr 11Cr 8.77Cr 8.21Cr 15Cr 1.05TCr 16Cr 103.58Cr 40Cr 509.93Cr 41Cr 40Cr 1.77TCr |
| Net income | -83.02L -96.12L -76.51L -71.61L -1.34Cr -91Cr -1.36Cr -9.03Cr -3.52Cr -44Cr -3.61Cr -3.53Cr -153.98Cr | 1.83Cr 2.12Cr 1.69Cr 1.58Cr 2.96Cr 201.46Cr 3.01Cr 20Cr 7.77Cr 98Cr 7.95Cr 7.79Cr 339.52Cr |
| Net Debt | -5.47Cr -6.34Cr -5.04Cr -4.72Cr -8.85Cr -602.2Cr -8.98Cr -60Cr -23Cr -293.11Cr -24Cr -23Cr -1.01TCr | -4.69Cr -5.43Cr -4.32Cr -4.04Cr -7.58Cr -515.78Cr -7.69Cr -51Cr -20Cr -251.05Cr -20Cr -20Cr -869.25Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
